| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/10/2007 | EP1740547A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 01/10/2007 | EP1740211A2 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 01/10/2007 | EP1417227B1 Peptides eefective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1353905B1 Piperidine/piperazine-type inhibitors of p38 kinase |
| 01/10/2007 | EP1301534B1 Mutated pf-4, its fragments and mutated fusion peptides, their analogues, corresponding dna, cdna and mrna sequences and their use for inhibiting angiogenesis |
| 01/10/2007 | EP1109803B1 Substituted imidazoles having cytokine inhibitory activity |
| 01/10/2007 | EP1087946B1 Aryl alkanoylpyridazines |
| 01/10/2007 | CN2855414Y Hot patching plaster |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1894232A Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 01/10/2007 | CN1894231A Furan derivatives as ep4 receptor antagonists |
| 01/10/2007 | CN1894222A Condensed pyramidine compounds as inhibitors of voltage-gated ion channels |
| 01/10/2007 | CN1894213A Substituted tetrahydrocarbazole and cyclopentanoindole derivatives |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893979A Remedy for angitis |
| 01/10/2007 | CN1893963A Production of hop extracts having oestrogenic and antiproliferative bioactivity |
| 01/10/2007 | CN1891703A Chelerythrine compound and its preparing method |
| 01/10/2007 | CN1891699A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891693A Therapeutic morpholino-substituted compounds |
| 01/10/2007 | CN1891687A Inflammatory factor receptor antagonistic active compound from microbe and its use |
| 01/10/2007 | CN1891286A Angong niuhuang Chinese medicine tablet and its preparing method |
| 01/10/2007 | CN1891283A Chinese medicine composition, and its preparing method and quality control method |
| 01/10/2007 | CN1891281A Chinese medicine preparation for treating wind-cold disease, and its preparing method |
| 01/10/2007 | CN1891273A Chinese medicine for treating rheumatic arthritis, lumbago and skelalgia |
| 01/10/2007 | CN1891267A Chinese medicine for treating atrophic arthritis |
| 01/10/2007 | CN1891245A Centella soft capsule and its preparing method |
| 01/10/2007 | CN1891243A Method for preparing thesium Chinese turcz total flavone |
| 01/10/2007 | CN1891235A Pheretima injection preparation and its preparing method |
| 01/10/2007 | CN1891211A Method for preparing curcumin lyophilized liposome |
| 01/10/2007 | CN1294142C 17 beta-carbothioate 17 alpha-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 01/10/2007 | CN1294141C 6 alpha., 9 alpha-difluoro-17.alpha.-[(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothioic acid s-fluoromethyl ester as an anti-inflammatory agent |
| 01/10/2007 | CN1294135C Pyrrolopyrimidines as protein kinase inhitibors |
| 01/10/2007 | CN1294133C Imidazo-pyrimidine derivatives as ligands for GABA receptors |
| 01/10/2007 | CN1294130C Substituted pyrazoles |
| 01/10/2007 | CN1294126C N-phenyl-arylsulfonamide compound, drug comprising the compound as active ingredient, intermediate for the compound and preparation method thereof |
| 01/10/2007 | CN1294120C Pyrrolidinyl metalloprotease inhibitor and its application |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293906C Chinese medicine preparation for treating pain caused by stagnation of wind-dampness |
| 01/10/2007 | CN1293864C Topical formulations containing ketoprofen stabilised with sulisobenzone |
| 01/09/2007 | US7161009 Antiinflammatory agents; skin disorders; central nervous system disorders |
| 01/09/2007 | US7161002 Compounds as antiinflammartory agents, antiproliferation agents and and anticancer agents from cyclodehydration of compounds |
| 01/09/2007 | US7160909 Cyclopenta[b]indole derivatives as sPLA2 inhibitors |
| 01/09/2007 | US7160904 Nicotine in therapeutic angiogenesis and vasculogenesis |
| 01/09/2007 | US7160903 Sulfonylaminocarboxylic acids |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160893 Antiarthritic agents for treating osteoarthritis or rheumatoid arthritis, treating diseases from tissue breakdown such as heart disease, cardiovascular disorders, inflammatory bowel disease, multiple sclerosis; enzyme inhibitors |
| 01/09/2007 | US7160889 Quinazoline compounds |
| 01/09/2007 | US7160883 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 01/09/2007 | US7160874 Phenylalanine derivatives |
| 01/09/2007 | US7160558 Coating and binding agent for pharmaceutical formulations with improved storage stability |
| 01/09/2007 | US7160541 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 01/09/2007 | CA2194352C Diagnostic methods and compositions relating to the proteoglycan proteins of cartilage breakdown |
| 01/09/2007 | CA2176511C Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 01/04/2007 | WO2007002742A1 Substituted [1,4]-diazepanes as cxcr3 antagonists and their use in the treatment of inflammatory disorders |
| 01/04/2007 | WO2007002057A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001975A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | WO2007001939A1 Tetrahydro-pyranopyrazole compounds displaying cannabinoid modulating activities |
| 01/04/2007 | WO2007001932A2 Substituted isothiazolones as inhibitors of cytosolic phospholipase a2 |
| 01/04/2007 | WO2007001058A1 Herpesvirus-derived therapeutic agent for pain |
| 01/04/2007 | WO2007000970A1 Therapeutic agent for pain |
| 01/04/2007 | WO2007000939A1 Therapeutic agent for local inflammation |
| 01/04/2007 | WO2007000924A1 Pharmaceutical composition comprising substance capable of inhibiting or promoting progranulin activity and screening method for substance capable of inhibiting or promoting progranulin activity |
| 01/04/2007 | WO2007000884A1 Prophylactic/therapeutic agent for bone/joint disease and screening method for the agent |
| 01/04/2007 | WO2007000334A1 Phenyl-pyrazole derivatives as non-steroidal glucocorticoid receptor ligands |
| 01/04/2007 | WO2007000038A1 Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against nsaid gastropathy |
| 01/04/2007 | WO2006124462A3 Compounds and compositions as protein kinase inhibitors |
| 01/04/2007 | WO2006120696A3 An improved pharmaceutical composition |
| 01/04/2007 | WO2006110917A3 Spiro-oxindole compounds and their uses as therapeutic agents |
| 01/04/2007 | WO2006108714A3 Tetrahydronaphthalene derivatives method for the production and the use thereof in the form of antiphlogistics |
| 01/04/2007 | WO2006069182A3 THIENOISOQUINOLINE-PHENYLSULFONAMIDES AND THEIR USE AS ER-NFkB INHIBITORS |
| 01/04/2007 | WO2005012297A9 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004800 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents |
| 01/04/2007 | US20070004788 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use |
| 01/04/2007 | US20070004764 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 01/04/2007 | US20070004755 Inhibiting the proteolytic activity of cathepsin S; 1-[4-(5-Chloro-1H-indol-3-yl)-piperazine-1-yl]-3-[5-methanesulfonyl-3-(4-trifluoromethyl-phenyl)-4,5,6,7-tetrahydro-pyrazolo[4,3-c]pyridin-1-yl]-propan-2-ol; antiarthritic agent; autoimmune disease: lupus, rheumatoid arthritis, and asthma |
| 01/04/2007 | US20070004754 Substituted pyrazoles |
| 01/04/2007 | US20070004747 Substituted pyrazoles |
| 01/04/2007 | US20070004740 phosphodiesterase 4 inhibitors which are naphthalene compounds such as 6,7-Dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene; asthma or inflammatory diseases |
| 01/04/2007 | US20070004739 Condensed polycyclic compounds |
| 01/04/2007 | US20070004738 Substituted pyrazoles |
| 01/04/2007 | US20070004721 Pteridine derivatives for the treatment of septic shock and tnf-a-related diseases |
| 01/04/2007 | US20070004718 Ion channel modulating compounds and uses thereof |
| 01/04/2007 | US20070004716 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 01/04/2007 | US20070004713 Therapeutic benimidazole compounds |
| 01/04/2007 | US20070004703 Use of 1-(dialkoxyphenylsulfonyl)-3-(pyrrolidino)-3-(phenyl)indolin-2-one compounds to treat hypertension, cardiovascular disorders, central nervous system disorders, psychological disorders, gastrointestinal disorders; affinity for V1b and V1a receptors of arginine-vasopressin |
| 01/04/2007 | US20070004678 Production and use of a polar lipid-rich fraction containing stearidonic acid and gamma linolenic acid from plant seeds and microbes |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070003645 Butyrospermum-triterpene fraction containing lupeol; alpha -amyrin and/or beta amyrin, and butyrospermol; plant extract |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003578 Chimeric protein comprising non-toxic pseudomonas exotoxin and type IV pilin sequences |
| 01/04/2007 | US20070003556 Modified antibodies against cd22 and utilization thereof |
| 01/04/2007 | US20070003544 Combination therapy for treatment of autoimmune diseases using b- cell depleting/immunoregulatory antibody combination |
| 01/04/2007 | US20070003510 Preparations containing an extract of eperua falcata and/or constituents of the latter |
| 01/04/2007 | CA2612585A1 Anti-inflammatory aryl nitrile compounds |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2609957A1 Carbon-linked substituted piperidines and derivatives thereof useful as histamine h3 antagonists |
| 01/03/2007 | EP1739176A1 Decoy nucleic acid to synoviolin gene promoter |